Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Lupin
Rises After Buying Cholesterol Drug for $38.6
Million 4:59 AM 9/29/2009
Bloomberg
Lupin Ltd bought the US rights for the cholesterol-lowering drug Antara from Oscient Pharmaceuticals Corp which
had filed for bankruptcy protection in July.
...
Merck
diabetes drug cut blood sugar over two years 2:29 AM 9/29/2009
MarketWatch
Merck & Co subsidiary Merck Sharp & Dohme reported that data over two
years showed that Januvia (sitagliptin) lowered blood sugar significantly for patients with type 2 diabetes.
...
FDA
eyes possible risk with iron drug 2:52 PM 9/28/2009
Reuters
The US FDA is looking into whether patients with myelodysplastic syndrome (MDS) are more
at risk for death and serious complications with Novartis AG's drug Exjade (deferasirox).
...
Glaxo
pulls vomiting drug on need for safety data 6:20 AM 9/28/2009
Reuters
GlaxoSmithKline will withdraw marketing applications for its drug Zunrisa
(casopitant) aimed at chemotherapy-induced and post-operative nausea and vomiting. Regulators want more safety
studies.
...
Johnson
& Johnson Buys 18% Stake In Crucell 4:40 AM 9/28/2009
Wall Street Journal
Johnson & Johnson bought an 18% stake in biotechnology company Crucell NV in
a deal to collaborate on the treatment and prevention of influenza.
...
Abbott
Nears Deal to Acquire Solvay's Pharmaceutical Unit 9:33 AM 9/27/2009
Wall Street Journal
Abbott Laboratories is close to announcing a deal to acquire
Solvay SA's pharmaceutical unit for about $7 billion. Abbott bested rival bidder Nycomed of Switzerland.
...
'Bumpy'
Start Seen for Swine Flu Vaccine Plan 5:04 AM 9/26/2009
New York Times
Five manufacturers and 90,000 distribution points. Expect shortages in some
places and oversupply in others. All the swine flu vaccine has been ordered by and paid for by the US government
including distribution costs and syringes.
...
Roche
US cancer drug trial enrollment suspended 3:55 PM 9/25/2009
Reuters
Roche Holding said enrollment into a late-stage US trial of Avastin in
breast cancer patients was suspended after six patients suffered congestive heart failure (CHF).
...
J&J
unit gets FDA approval for psoriasis drug 2:19 PM 9/25/2009
Forbes
Johnson & Johnson's Centocor Ortho Biotech unit received US FDA approval for Stelara as a
treatment for severe plaque psoriasis.
...
Wyeth
wins EU recommendation for Prevenar 13 1:23 PM 9/25/2009
Reuters
The European Medicines Agency recommended approval of Wyeth's more protective
Prevnar/Prevenar 13 designed to protect against 13 serotypes of streptococcus pneumoniae.
...
EU
agency backs Zeltia drug for ovarian cancer 12:21 PM 9/25/2009
Reuters
Zeltia soared after advisors to European regulators recommended the
pharmaceutical firm's Yondelis drug for use in the treatment of ovarian cancer.
...
Allos
Therapeutics' cancer drug gets FDA nod 6:18 AM 9/25/2009
Reuters
Allos Therapeutics said the US FDA granted accelerated approval for its experimental
drug Folotyn to treat relapsed or refractory peripheral T-cell lymphoma (PTCL), an aggressive white blood cell
cancer.
...
EU
agency backs two H1N1 flu vaccines for approval 5:06 AM 9/25/2009
Reuters
European healthcare regulators recommended swine flu vaccines Pandemrix and
Focetria from GlaxoSmithKline and Novartis for approval. Mass vaccination to start within weeks.
...
FDA
Admits Error in Approving Knee Device 4:26 AM 9/25/2009
New York Times
ReGen Biologics Inc's Menaflex knee device found unsafe. Pressure from four NJ
Democrats (Menendez, Lautenberg, Pallone, Rothman) made agency managers overrule scientists. Obama may ask the
four to drop out to prove Paterson move was not power grab.
...
Doctor
group calls for warnings on new prescription drugs 3:58 PM 9/24/2009
Los Angeles Times
The US FDA should place limits on the advertising of newly
approved drugs with a symbol alerting consumers. The general patient population is less healthy, more diverse,
and less careful compared to those in clinicals. The FDA knows safety and effectiveness problems will arise in
the larger population.
...
<- Day Earlier | Today's News
|
